SCHEMBL3361966

SCHEMBL3361966

COC(=O)C1CSCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5224314 1.00
SCHEMBL11122946 1.00
Hydrochloric Acid SCHEMBL201249 0.98 KMT2A (0.41)
Hydrochloric Acid SCHEMBL201248 0.98 KMT2A (0.41)
Hydrochloric Acid SCHEMBL7350919 0.98 KMT2A (0.41)
Hydrochloric Acid SCHEMBL6392619 0.96 KMT2A (0.40)
Hydrochloric Acid SCHEMBL6395633 0.96 KMT2A (0.40)
SCHEMBL28052844 0.83
SCHEMBL4571091 0.82 KMT2A (0.41)
SCHEMBL5493487 0.82 KMT2A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11401241-B2 Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease VIRGINIA COMMONWEALTH UNIVERSITY (US) 2022-08-02 US disclosed
CN-114630822-A Biaryl dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2022-06-14 CN disclosed
US-20210238301-A1 NOVEL BENZODIAZEPINE DERIVATIVES IMMUNOGEN, INC. 2021-08-05 US disclosed
US-10947315-B2 Benzodiazepine derivatives IMMUNOGEN, INC. (US) 2021-03-16 US disclosed
US-20210002225-A1 AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-01-07 US disclosed
WO-2019182938-A1 AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2019-09-26 WO disclosed
US-20190276552-A1 NOVEL BENZODIAZEPINE DERIVATIVES IMMUNOGEN, INC. 2019-09-12 US disclosed
CN-109662964-A For improving the method and composition of cognitive function 约翰斯.霍普金斯大学 2019-04-23 CN disclosed
CN-109662961-A For improving the method and composition of cognitive function 约翰斯霍普金斯大学 2019-04-23 CN disclosed
US-10208127-B2 Benzodiazepine derivatives IMMUNOGEN, INC. (US) 2019-02-19 US disclosed
WO-2003011824-A1 BICYCLIC MODULATORS OF ANDROGEN RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-02-13 WO disclosed
WO-2003000180-A2 DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES MERCK & CO., INC. (US) 2003-01-03 WO disclosed
CN-1262275-A Substituted thiazol [3,2-alpha] azatropylidene derivatives EISAI CO LTD (JP) 2000-08-09 CN disclosed
CN-1053908-C Substituted thiazolo [3, 2-alpha ] aza * derivatives EISAI CO LTD (JP) 2000-06-28 CN disclosed
CN-1134152-A Substituted thiazolo [3, 2-alpha ] aza * derivatives EISAI CO LTD (JP) 1996-10-23 CN disclosed
US-5075293-A Control leafhoppers on rice plants THE DOW CHEMICAL COMPANY (US) 1991-12-24 US disclosed
US-4804660-A PARKINSON'S DISEASE; VASOCONSTRICTION SANDOZ LTD. (CH) 1989-02-14 US disclosed
US-4542135-A VENOTONIZING AGENTS, PARKINSON*S DISEASE, HYPERTENSIVE AGENTS, ALKALOIDS SANDOZ LTD. (CH) 1985-09-17 US disclosed
US-4374249-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1983-02-15 US disclosed
US-4283407-A ANTIHYPERTENSIVE AGENTS SCIENCE UNION ET CIE (FR) 1981-08-11 US disclosed